Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol for left ventricular hypertrophy in type 2 diabetes and stage 3 chronic kidney disease
2011-003025-10Phase 4Completed
- Sponsor
- King's College London
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in left ventricular hypertrophy (LVH), type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) comparing Calcitriol with Placebo (2 arms). Primary endpoint: Left ventricular mass index. Started Sep 2011; status: completed.
02
Drugs
calcitriol
03
Conditions
left ventricular hypertrophy (LVH)type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2011-003025-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003025-10.